Halesha D. Basavarajappa

Aminopyrazinamides: Novel and Specific GyrB Inhibitors that Kill Replicating and Nonreplicating <i>Mycobacterium tuberculosis</i>

Pravin S. Shirude, Prashanti Madhavapeddi, Julie A. Tucker et al. · ACS Chemical Biology · 2012 · 86 citations

Crystal Structure, Tuberculosis Prevention, Pharmacotherapy +21

Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B

Manoj Kale, Anandkumar Raichurkar, Shahul Hameed P et al. · Journal of Medicinal Chemistry · 2013 · 66 citations · Full text

Antiparasitic Agent, Molecular Biology, Antimicrobial Chemotherapy +21

Ferrochelatase is a therapeutic target for ocular neovascularization

Halesha D. Basavarajappa, Rania S. Sulaiman, Xiaoping Qi et al. · EMBO Molecular Medicine · 2017 · 59 citations · Full text

The first synthesis of the antiangiogenic homoisoflavanone, cremastranone

Bit Lee, Halesha D. Basavarajappa, Rania S. Sulaiman et al. · Organic & Biomolecular Chemistry · 2014 · 58 citations · Full text

Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy

Ramesh R. Kale, Manoj Kale, David Waterson et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 41 citations · Full text

Medicinal Chemistry, Antitubercular Activity, Biochemistry +11